# Phase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease.

> **NCT07398508** · PHASE1,PHASE2 · RECRUITING · sponsor: **Stephen G. Kaler** · enrollment: 6 (estimated)

## Conditions studied

- Menkes Disease

## Interventions

- **DRUG:** Droxidopa Oral Product
- **OTHER:** Placebo Control

## Key facts

- **NCT ID:** NCT07398508
- **Lead sponsor:** Stephen G. Kaler
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2030-06-30
- **Final completion:** 2030-06-30
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07398508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07398508, "Phase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT07398508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*